Analysis for Abbott Laboratories
Analysis summary
Abbott Laboratories (ABT) currently has a total score of 39 points, placing it in the weak range. The score is made up of Performance (38), Stability (54) and Trend (18). The profile is clearly uneven: Stability stands out while Trend lags.
Performance scores 38 points (weak). Least weak metric: 10Y return at 201.3 %. Main drag: 1Y return at -14.3 %. This suggests stronger long-term than short-term performance.
Stability scores 54 points (neutral). Best-ranked metric: max drawdown (10Y) at -36.2 %. Weaker metric: Sharpe ratio (90d) at -1.03. Higher Stability points are better and typically reflect calmer swings and smaller drawdowns—but prices can still fall.
Trend scores 18 points (very weak). Trend signals are mostly negative right now. Least weak metric: 12M momentum at -6.3 %. Main drag: trend strength at -0.78.
Overall, the profile has a clear strength in Stability, while Trend is the main limiter. On a metric level, max drawdown (10Y) stands out, while Sharpe ratio (90d) is the main weak spot.
(Historical evaluation, not investment advice.)
Metrics
Stability
FAQ
- What investor type does Abbott Laboratories fit best in FoxScore?
- Abbott Laboratories shows a mixed profile: stability is strongest, but trend lags noticeably. Use the sub-scores as a radar, then decide based on the metrics whether the risk/return profile fits you.
- How meaningful is the available history for Abbott Laboratories?
- Abbott Laboratories currently has about 15 years of price history available. That covers multiple market cycles including crisis phases, making long-term interpretation of returns, drawdowns and trend shifts more reliable.
- What is FoxScore good for — and what is it not for?
- FoxScore is an analysis and comparison tool: it helps you sort assets quickly, compare profiles and spot strengths/weaknesses. It’s not a substitute for your own research or fundamental analysis, and it’s not a buy/sell recommendation.